Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Recent advances in hair loss treatments show significant progress.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Bioactive molecules show promise for improving skin repair and regeneration by overcoming current challenges with further research.

The HOXC13 gene affects different hair proteins in cashmere goats in varied ways and is controlled by a feedback loop and other factors.

Hydroxychloroquine may help treat alopecia areata in children.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Centella asiatica extract may help promote hair growth by blocking a specific cell signaling pathway.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Minoxidil, applied on the skin or taken orally, can improve hair growth in kids, but more research is needed due to possible side effects.

COVID-19 doesn't make alopecia areata worse.

Leflunomide and anthralin may effectively treat severe alopecia areata.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Ruxolitinib treatment may cause eyelash growth.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.